Cargando…
Effects of an Intervention with Selenium and Coenzyme Q(10) on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect—A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial
Background: Ageing is associated with cardiovascular disease (CVD). As no single biomarker reflects the full ageing process, we aimed to investigate five CVD- and age-related markers and the effects of selenium and coenzyme Q10 intervention to elucidate the mechanisms that may influence the course o...
Autores principales: | Alehagen, Urban, Alexander, Jan, Aaseth, Jan O., Larsson, Anders, Svensson, Erland, Opstad, Trine B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340529/ https://www.ncbi.nlm.nih.gov/pubmed/37443807 http://dx.doi.org/10.3390/cells12131773 |
Ejemplares similares
-
Impact of Selenium on Biomarkers and Clinical Aspects Related to Ageing. A Review
por: Alehagen, Urban, et al.
Publicado: (2021) -
Selenium and Coenzyme Q(10) Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality—Sub-Study of a Randomized Clinical Trial
por: Opstad, Trine Baur, et al.
Publicado: (2022) -
Increased SIRT1 Concentration Following Four Years of Selenium and Q(10) Intervention Associated with Reduced Cardiovascular Mortality at 10-Year Follow-Up—Sub-Study of a Previous Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial
por: Opstad, Trine Baur, et al.
Publicado: (2023) -
Selenium and Coenzyme Q10 Supplementation Improves Renal Function in Elderly Deficient in Selenium: Observational Results and Results from a Subgroup Analysis of a Prospective Randomised Double-Blind Placebo-Controlled Trial
por: Alehagen, Urban, et al.
Publicado: (2020) -
Improved cardiovascular health by supplementation with selenium and coenzyme Q10: applying structural equation modelling (SEM) to clinical outcomes and biomarkers to explore underlying mechanisms in a prospective randomized double-blind placebo-controlled intervention project in Sweden
por: Alehagen, Urban, et al.
Publicado: (2022)